Cancer News and Research

Latest Cancer News and Research

New radiotherapy system benefits high-risk patients

A new radiotherapy system that combines high-tech imaging with precision tumor-targeting capability is helping cancer specialists at Stony Brook University Medical Center treat patients.

10 Dec 2007

Multiple myeloma clinical trial shows distinct survival benefit with lower dose of steroids

Results of Eastern Cooperative Oncology Group Phase III clinical trial E4A03, for multiple myeloma, showing significantly better overall survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone, were reported today by S. Vincent Rajkumar, M.D. at the American Society of Hematology's annual meeting.

10 Dec 2007

Tuberculosis found in 500,000-year-old human

Although most scientists believe tuberculosis emerged only several thousand years ago, new research from The University of Texas at Austin reveals the most ancient evidence of the disease has been found in a 500,000-year-old human fossil from Turkey.

10 Dec 2007

Effects of diet and physical activity on the possibility of developing lung cancer

By simply eating four or more servings of green salad a week and working in the garden once or twice a week, smokers and nonsmokers alike may be able to substantially reduce the risk of developing lung cancer, say researchers at The University of Texas M. D. Anderson Cancer Center.

10 Dec 2007

Male circumcision

Circumcision is one of the commonest surgical procedures performed on males. Opponents argue that infant circumcision can cause both physical and psychological harm, while recent evidence shows that circumcision is medically beneficial.

10 Dec 2007

More good Gleevec news

Gleevec, the targeted cancer pill that has saved more than 100,000 lives, now is saving more children with a dire leukemia, as well as preventing disease progression with long term use in adults with chronic myeloid leukemia.

10 Dec 2007

Nilotinib and Dasatinib show promise as therapy for chronic myelogenous leukemia

Two drugs approved for use as second line therapy for chronic myelogenous leukemia are showing promising results as frontline therapy for newly diagnosed patients in two clinical trials, research teams led by scientists at The University of Texas M. D. Anderson Cancer Center report at the 49th annual meeting of the American Society of Hematology.

10 Dec 2007

Complete response with oblimersen combination improves survival of CLL patients

Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.

10 Dec 2007

Antibacterial chemical in bath soaps disrupts hormone activities

A new UC Davis study shows that a common antibacterial chemical added to bath soaps can alter hormonal activity in rats and in human cells in the laboratory - and does so by a previously unreported mechanism.

10 Dec 2007

New approach to study flu drug resistance

Researchers have created a new approach for studying resistance to Neuraminidase Inhibitors (NI) in influenza.

10 Dec 2007

Mobile phones increase the risk of tumours

Israeli researchers say they have found that the regular use of mobile phones increases the risk of developing tumours.

10 Dec 2007

Shampoo damaging the environment

According to a report from the Royal Society of Chemistry (RSC), Britain's environment is under threat from shampoo.

10 Dec 2007

Scientists say children living near nuclear power plants have a higher risk of cancer

Scientists in Germany say young children living near nuclear power plants have a significantly higher risk of developing leukemia and other forms of cancer.

10 Dec 2007

Antioxidant cocktail shows good results in fight against prostate cancer

Prostate cancer trials undertaken at the University of Sydney have provided exciting results with reductions of up to 25 per cent of tumour growth in mouse models.

9 Dec 2007

Fruits and raw veggies reduce the risk of cancer

The latest research says that by eating just three servings a month of raw broccoli or cabbage a person can reduce their risk of bladder cancer by as much as 40 percent.

9 Dec 2007

Reprogrammed stem cells cure sickle cell anaemia

Scientists in the U.S. have made a breakthrough in the fight against sickle cell anaemia, a blood disease caused by a defect in a single gene.

9 Dec 2007

Topical treatment for age spots

Sun-induced skin damage can cause brown age spots, especially on oft-exposed areas like the hands and face.

5 Dec 2007

Many cancers caused by infections

Cancer -- popularly understood as a result of mutations or mistakes within the genetic code in cells -- is also caused by infections from viruses, bacteria and parasites.

5 Dec 2007

Court approves Biomira's move to U.S. and name change to Oncothyreon

Biomira Inc. has announced that the Alberta Court of Queen's Bench issued a Final Order approving the plan of arrangement under which the Company will move to the United States and change its name to Oncothyreon Inc.

5 Dec 2007

Breast MRI spots other cancers, may alter treatment plan

In about 20 percent of women with breast cancer who plan to undergo a lumpectomy, breast magnetic resonance imaging reveals important diagnostic information that alters their treatment plan, University of Florida surgeons reported today (Dec. 5).

5 Dec 2007